Share Price and Basic Stock Data
Last Updated: November 6, 2025, 5:12 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Envair Electrodyne Ltd operates in the electric equipment sector, specifically focusing on gensets and turbines. The company recorded a price of ₹95.9 with a market capitalization of ₹44.5 Cr. Notably, the sales figures have shown significant volatility over recent quarters. Sales stood at ₹0.08 Cr in June 2022, peaking at ₹0.89 Cr in December 2022, before dropping to ₹0.00 Cr in subsequent quarters until September 2023, when sales recovered slightly to ₹0.31 Cr. This erratic revenue trend highlights potential challenges in demand stability or operational efficiency. The annual sales for FY 2023 were reported at ₹0.97 Cr, down from ₹4.49 Cr in FY 2022, indicating a drastic decline in operational performance. The company’s ability to generate consistent revenue remains a concern, especially given the unpredictable sales trajectory over the past few quarters.
Profitability and Efficiency Metrics
Profitability metrics for Envair Electrodyne Ltd reveal a concerning picture. The company reported a net profit of ₹-0.47 Cr for FY 2025, following a loss of ₹0.81 Cr in FY 2024 and a profit of ₹6.08 Cr in FY 2023. Operating profit margins have fluctuated dramatically, with an operating profit margin (OPM) of -103.09% in FY 2023 and -325.00% projected for FY 2024, indicating substantial operational inefficiencies. The return on equity (ROE) was recorded at 5.88% and return on capital employed (ROCE) at 2.25%, both of which are relatively low compared to industry standards. Additionally, the interest coverage ratio (ICR) was reported at 0.00x, highlighting the company’s inability to cover interest expenses with its earnings, a critical red flag for investors. Overall, the profitability and efficiency indicators suggest a pressing need for operational restructuring to enhance financial health.
Balance Sheet Strength and Financial Ratios
Envair Electrodyne Ltd’s balance sheet reflects a mixed picture of financial health. The total liabilities stood at ₹8.88 Cr, with borrowings marginally increasing to ₹0.02 Cr in FY 2025, indicating a low leverage position. The company holds reserves of ₹3.64 Cr, which is a positive sign, suggesting some level of retained earnings. However, the price-to-book value (P/BV) ratio is notably high at 5.32x, raising questions about the valuation relative to its equity. The current ratio is robust at 14.72, indicating a strong liquidity position, which is much higher than typical sector norms. Despite these strengths, the asset turnover ratio remained at 0.00%, indicating inefficient use of assets to generate revenue. Overall, while the liquidity position appears strong, the high P/BV ratio and stagnant asset turnover raise concerns about the company’s operational effectiveness.
Shareholding Pattern and Investor Confidence
The shareholding pattern for Envair Electrodyne Ltd indicates a stable ownership structure, with promoters holding 57.52% of the shares as of March 2025, which suggests a strong commitment from the founding members. The public holds 42.48%, with the number of shareholders standing at 2,683, reflecting a diverse investor base. However, the lack of institutional investment from Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may indicate a lack of confidence or interest from larger investors, potentially limiting the stock’s appeal for institutional investment. The relatively stable promoter holding over recent quarters is a positive aspect, as it may provide a sense of security to retail investors. However, the declining public shareholding from 46.78% in September 2022 to 42.48% in March 2025 could raise concerns about the loss of investor confidence and the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Envair Electrodyne Ltd faces a challenging environment characterized by its inconsistent revenue performance and profitability issues. The company’s ability to stabilize sales and improve operational efficiency will be critical to regaining investor confidence. Key risks include the ongoing operational losses and the high P/BV ratio, which suggests that the stock may be overvalued relative to its current financial performance. Additionally, the lack of institutional backing could hinder growth potential. However, the solid liquidity position and stable promoter holding present opportunities for revitalization, particularly if management can implement effective cost-control measures and enhance operational productivity. In an ideal scenario, if the company successfully improves its revenue generation and profitability metrics, it could attract institutional investors and regain market confidence, leading to a potential turnaround. Conversely, failure to address these operational challenges may result in continued financial strain and diminished investor appeal.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Envair Electrodyne Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Envair Electrodyne Ltd | 35.6 Cr. | 76.8 | 182/68.0 | 17.8 | 0.00 % | 2.25 % | 5.88 % | 10.0 | |
| Solex Energy Ltd | 1,821 Cr. | 1,685 | 1,826/631 | 46.0 | 146 | 0.03 % | 28.2 % | 38.7 % | 10.0 |
| Honda India Power Products Ltd | 2,545 Cr. | 2,505 | 3,794/1,815 | 34.7 | 851 | 3.99 % | 12.8 % | 9.47 % | 10.0 |
| Industry Average | 2,183.00 Cr | 1,422.27 | 40.35 | 338.27 | 1.34% | 14.42% | 18.02% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.08 | 0.00 | 0.89 | 0.00 | 0.00 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.48 | 0.21 | 0.54 | 0.18 | 0.17 | 0.42 | 0.58 | 0.58 | 0.06 | 0.09 | 0.08 | 0.35 | 0.08 |
| Operating Profit | -0.40 | -0.21 | 0.35 | -0.18 | -0.17 | -0.11 | -0.58 | -0.58 | -0.06 | -0.09 | -0.08 | -0.35 | -0.08 |
| OPM % | -500.00% | 39.33% | -35.48% | ||||||||||
| Other Income | 10.43 | 0.00 | 0.03 | -2.22 | 0.21 | 0.01 | 0.00 | 0.16 | 0.20 | 0.33 | 0.11 | 0.12 | 0.21 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 10.02 | -0.21 | 0.38 | -2.40 | 0.04 | -0.10 | -0.62 | -0.42 | 0.14 | 0.24 | 0.03 | -0.23 | 0.13 |
| Tax % | 22.26% | 0.00% | 0.00% | -22.08% | 125.00% | -10.00% | -82.26% | 45.24% | 0.00% | 0.00% | 2,133.33% | 0.00% | 0.00% |
| Net Profit | 7.80 | -0.21 | 0.38 | -1.87 | -0.01 | -0.09 | -0.11 | -0.60 | 0.14 | 0.24 | -0.61 | -0.23 | 0.13 |
| EPS in Rs | 16.81 | -0.45 | 0.82 | -4.03 | -0.02 | -0.19 | -0.24 | -1.29 | 0.30 | 0.52 | -1.31 | -0.50 | 0.28 |
Last Updated: August 19, 2025, 7:20 pm
Below is a detailed analysis of the quarterly data for Envair Electrodyne Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.35 Cr. (Mar 2025) to 0.08 Cr., marking a decrease of 0.27 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.08 Cr.. The value appears strong and on an upward trend. It has increased from -0.35 Cr. (Mar 2025) to -0.08 Cr., marking an increase of 0.27 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.09 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from -0.23 Cr. (Mar 2025) to 0.13 Cr., marking an increase of 0.36 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from -0.23 Cr. (Mar 2025) to 0.13 Cr., marking an increase of 0.36 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.28. The value appears strong and on an upward trend. It has increased from -0.50 (Mar 2025) to 0.28, marking an increase of 0.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.15 | 5.53 | 4.12 | 4.76 | 4.07 | 3.38 | 3.49 | 0.79 | 4.49 | 0.97 | 0.40 | -0.22 | 0.00 |
| Expenses | 5.51 | 5.75 | 4.72 | 4.91 | 4.78 | 6.18 | 4.89 | 2.28 | 5.30 | 1.97 | 1.70 | 0.37 | 0.60 |
| Operating Profit | -0.36 | -0.22 | -0.60 | -0.15 | -0.71 | -2.80 | -1.40 | -1.49 | -0.81 | -1.00 | -1.30 | -0.59 | -0.60 |
| OPM % | -6.99% | -3.98% | -14.56% | -3.15% | -17.44% | -82.84% | -40.11% | -188.61% | -18.04% | -103.09% | -325.00% | ||
| Other Income | 0.71 | -0.48 | 0.17 | 0.06 | 4.41 | 0.15 | 0.07 | 0.08 | 0.22 | 8.81 | 0.29 | 0.77 | 0.77 |
| Interest | 0.02 | 0.04 | 0.05 | 0.11 | 0.12 | 0.05 | 0.06 | 0.09 | 0.09 | 0.02 | 0.09 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.21 | 0.15 | 0.11 | 0.11 | 0.08 | 0.10 | 0.10 | 0.09 | 0.01 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.05 | -0.95 | -0.63 | -0.31 | 3.47 | -2.78 | -1.49 | -1.60 | -0.77 | 7.78 | -1.10 | 0.18 | 0.17 |
| Tax % | -140.00% | -1.05% | 0.00% | 0.00% | 6.05% | 16.91% | 0.00% | 0.00% | 0.00% | 21.85% | -25.45% | 355.56% | |
| Net Profit | 0.11 | -0.94 | -0.63 | -0.31 | 3.25 | -3.25 | -1.50 | -1.61 | -0.77 | 6.08 | -0.81 | -0.47 | -0.47 |
| EPS in Rs | 0.36 | -3.09 | -2.07 | -1.02 | 10.69 | -10.69 | -3.23 | -3.47 | -1.66 | 13.10 | -1.75 | -1.01 | -1.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -954.55% | 32.98% | 50.79% | 1148.39% | -200.00% | 53.85% | -7.33% | 52.17% | 889.61% | -113.32% | 41.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 987.52% | 17.81% | 1097.59% | -1348.39% | 253.85% | -61.18% | 59.51% | 837.44% | -1002.93% | 155.30% |
Envair Electrodyne Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 11% |
| 3 Years: | 12% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 37% |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | -25% |
| 5 Years: | -15% |
| 3 Years: | -9% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:26 pm
Balance Sheet
Last Updated: July 25, 2025, 1:21 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 |
| Reserves | 0.67 | -0.46 | -1.09 | -1.51 | 1.74 | -0.28 | 0.18 | -1.39 | -2.17 | 3.88 | 3.07 | 3.64 |
| Borrowings | 0.39 | 0.13 | 0.41 | 1.12 | 0.67 | 0.61 | 2.24 | 2.49 | 2.77 | 0.00 | 0.00 | 0.02 |
| Other Liabilities | 1.76 | 1.57 | 1.53 | 1.66 | 1.99 | 1.60 | 1.56 | 1.32 | 1.74 | 1.34 | 0.37 | 0.58 |
| Total Liabilities | 5.86 | 4.28 | 3.89 | 4.31 | 7.44 | 4.97 | 8.62 | 7.06 | 6.98 | 9.86 | 8.08 | 8.88 |
| Fixed Assets | 1.36 | 0.92 | 0.84 | 0.78 | 0.80 | 1.08 | 1.05 | 0.95 | 0.86 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.07 | 0.07 | 0.13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.26 | 2.46 |
| Other Assets | 4.50 | 3.29 | 2.98 | 3.40 | 6.56 | 3.81 | 7.49 | 6.03 | 6.04 | 9.86 | 6.82 | 6.42 |
| Total Assets | 5.86 | 4.28 | 3.89 | 4.31 | 7.44 | 4.97 | 8.62 | 7.06 | 6.98 | 9.86 | 8.08 | 8.88 |
Below is a detailed analysis of the balance sheet data for Envair Electrodyne Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.64 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.64 Cr..
- For Reserves, as of Mar 2025, the value is 3.64 Cr.. The value appears strong and on an upward trend. It has increased from 3.07 Cr. (Mar 2024) to 3.64 Cr., marking an increase of 0.57 Cr..
- For Borrowings, as of Mar 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 0.02 Cr., marking an increase of 0.02 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.37 Cr. (Mar 2024) to 0.58 Cr., marking an increase of 0.21 Cr..
- For Total Liabilities, as of Mar 2025, the value is 8.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.08 Cr. (Mar 2024) to 8.88 Cr., marking an increase of 0.80 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 2.46 Cr.. The value appears strong and on an upward trend. It has increased from 1.26 Cr. (Mar 2024) to 2.46 Cr., marking an increase of 1.20 Cr..
- For Other Assets, as of Mar 2025, the value is 6.42 Cr.. The value appears to be declining and may need further review. It has decreased from 6.82 Cr. (Mar 2024) to 6.42 Cr., marking a decrease of 0.40 Cr..
- For Total Assets, as of Mar 2025, the value is 8.88 Cr.. The value appears strong and on an upward trend. It has increased from 8.08 Cr. (Mar 2024) to 8.88 Cr., marking an increase of 0.80 Cr..
Notably, the Reserves (3.64 Cr.) exceed the Borrowings (0.02 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.75 | -0.35 | -1.01 | -1.27 | -1.38 | -3.41 | -3.64 | -3.98 | -3.58 | -1.00 | -1.30 | -0.61 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122.61 | 98.35 | 102.77 | 108.89 | 176.67 | 96.11 | 106.68 | 314.18 | 50.40 | 395.10 | 0.00 | 0.00 |
| Inventory Days | 48.41 | 72.29 | 60.06 | 88.16 | 118.67 | 133.40 | 129.13 | 404.82 | 39.14 | 117.54 | 0.00 | 0.00 |
| Days Payable | 126.90 | 104.29 | 100.11 | 102.08 | 116.87 | 116.73 | 113.63 | 358.36 | 57.00 | 123.73 | ||
| Cash Conversion Cycle | 44.12 | 66.35 | 62.72 | 94.97 | 178.47 | 112.78 | 122.17 | 360.63 | 32.53 | 388.92 | 0.00 | 0.00 |
| Working Capital Days | 170.81 | 112.21 | 59.36 | 32.97 | 326.44 | 33.48 | 55.43 | 582.15 | 190.22 | 451.55 | 100.38 | -132.73 |
| ROCE % | -15.05% | -8.22% | -22.88% | -8.38% | -15.80% | -62.36% | -27.42% | -23.59% | -12.39% | -8.43% | -12.45% | 2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.00 | -1.76 | 13.11 | -1.67 | -3.39 |
| Diluted EPS (Rs.) | -1.00 | -1.76 | 13.11 | -1.67 | -3.39 |
| Cash EPS (Rs.) | -1.00 | -1.75 | 13.12 | -1.46 | -3.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.84 | 16.61 | 18.37 | 5.33 | 6.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.84 | 16.61 | 18.37 | 5.33 | 6.99 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.85 | 2.09 | 9.99 | 1.70 |
| PBDIT / Share (Rs.) | 0.38 | -2.26 | -1.26 | -1.36 | -3.14 |
| PBIT / Share (Rs.) | 0.38 | -2.26 | -1.27 | -1.56 | -3.36 |
| PBT / Share (Rs.) | 0.38 | -2.36 | 16.78 | -1.66 | -3.46 |
| Net Profit / Share (Rs.) | -1.00 | -1.75 | 13.11 | -1.66 | -3.46 |
| PBDIT Margin (%) | 0.00 | -264.57 | -59.96 | -13.60 | -184.37 |
| PBIT Margin (%) | 0.00 | -264.57 | -60.55 | -15.59 | -197.28 |
| PBT Margin (%) | 0.00 | -275.78 | 801.06 | -16.61 | -203.10 |
| Net Profit Margin (%) | 0.00 | -205.08 | 625.68 | -16.61 | -203.10 |
| Return on Networth / Equity (%) | -5.62 | -10.56 | 71.35 | -31.17 | -49.49 |
| Return on Capital Employeed (%) | 2.10 | -13.63 | -6.90 | -15.29 | -29.58 |
| Return On Assets (%) | -5.23 | -10.08 | 62.11 | -11.03 | -22.74 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.91 | 0.62 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 1.12 | 0.76 |
| Asset Turnover Ratio (%) | 0.00 | 0.04 | 0.11 | 0.66 | 0.10 |
| Current Ratio (X) | 14.72 | 17.60 | 7.58 | 2.60 | 3.27 |
| Quick Ratio (X) | 14.72 | 17.60 | 7.27 | 2.40 | 2.93 |
| Inventory Turnover Ratio (X) | 0.00 | 0.20 | 0.49 | 8.05 | 0.69 |
| Interest Coverage Ratio (X) | 0.00 | -23.62 | 0.00 | -13.34 | -31.66 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | -17.31 | 0.00 | -15.28 | -33.88 |
| Enterprise Value (Cr.) | 38.04 | 91.76 | 22.09 | 11.63 | 14.19 |
| EV / Net Operating Revenue (X) | 0.00 | 231.01 | 22.73 | 2.51 | 17.94 |
| EV / EBITDA (X) | 214.18 | -87.31 | -37.90 | -18.43 | -9.73 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 246.02 | 29.57 | 2.20 | 18.33 |
| Price / BV (X) | 5.32 | 12.68 | 3.37 | 4.13 | 4.47 |
| Price / Net Operating Revenue (X) | 0.00 | 246.03 | 29.58 | 2.20 | 18.34 |
| EarningsYield | -0.01 | -0.01 | 0.21 | -0.07 | -0.11 |
After reviewing the key financial ratios for Envair Electrodyne Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 5. It has increased from -1.76 (Mar 24) to -1.00, marking an increase of 0.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 5. It has increased from -1.76 (Mar 24) to -1.00, marking an increase of 0.76.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 3. It has increased from -1.75 (Mar 24) to -1.00, marking an increase of 0.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.84. It has increased from 16.61 (Mar 24) to 17.84, marking an increase of 1.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.84. It has increased from 16.61 (Mar 24) to 17.84, marking an increase of 1.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.85 (Mar 24) to 0.00, marking a decrease of 0.85.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -2.26 (Mar 24) to 0.38, marking an increase of 2.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from -2.26 (Mar 24) to 0.38, marking an increase of 2.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from -2.36 (Mar 24) to 0.38, marking an increase of 2.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 2. It has increased from -1.75 (Mar 24) to -1.00, marking an increase of 0.75.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -264.57 (Mar 24) to 0.00, marking an increase of 264.57.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -264.57 (Mar 24) to 0.00, marking an increase of 264.57.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -275.78 (Mar 24) to 0.00, marking an increase of 275.78.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -205.08 (Mar 24) to 0.00, marking an increase of 205.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.62. This value is below the healthy minimum of 15. It has increased from -10.56 (Mar 24) to -5.62, marking an increase of 4.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 10. It has increased from -13.63 (Mar 24) to 2.10, marking an increase of 15.73.
- For Return On Assets (%), as of Mar 25, the value is -5.23. This value is below the healthy minimum of 5. It has increased from -10.08 (Mar 24) to -5.23, marking an increase of 4.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 14.72. This value exceeds the healthy maximum of 3. It has decreased from 17.60 (Mar 24) to 14.72, marking a decrease of 2.88.
- For Quick Ratio (X), as of Mar 25, the value is 14.72. This value exceeds the healthy maximum of 2. It has decreased from 17.60 (Mar 24) to 14.72, marking a decrease of 2.88.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.20 (Mar 24) to 0.00, marking a decrease of 0.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -23.62 (Mar 24) to 0.00, marking an increase of 23.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -17.31 (Mar 24) to 0.00, marking an increase of 17.31.
- For Enterprise Value (Cr.), as of Mar 25, the value is 38.04. It has decreased from 91.76 (Mar 24) to 38.04, marking a decrease of 53.72.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 231.01 (Mar 24) to 0.00, marking a decrease of 231.01.
- For EV / EBITDA (X), as of Mar 25, the value is 214.18. This value exceeds the healthy maximum of 15. It has increased from -87.31 (Mar 24) to 214.18, marking an increase of 301.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 246.02 (Mar 24) to 0.00, marking a decrease of 246.02.
- For Price / BV (X), as of Mar 25, the value is 5.32. This value exceeds the healthy maximum of 3. It has decreased from 12.68 (Mar 24) to 5.32, marking a decrease of 7.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 246.03 (Mar 24) to 0.00, marking a decrease of 246.03.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Envair Electrodyne Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.1% (Industry Average ROCE: 14.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.62% (Industry Average ROE: 18.02%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 14.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 40.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electric Equipment - Gensets/Turbines | Office No 123, Wing A Sohrab Hall, 21 Pune Maharashtra 411001 | cs@envair.in www.envaire.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Nagpal | Managing Director |
| Mr. Harish Kumar Agarwal | Director |
| Mr. Satish Kumar Avasthi | Independent Director |
| Ms. Rashmi Sharma | Independent Director |
FAQ
What is the intrinsic value of Envair Electrodyne Ltd?
Envair Electrodyne Ltd's intrinsic value (as of 06 November 2025) is 12.81 which is 83.32% lower the current market price of 76.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 35.6 Cr. market cap, FY2025-2026 high/low of 182/68.0, reserves of ₹3.64 Cr, and liabilities of 8.88 Cr.
What is the Market Cap of Envair Electrodyne Ltd?
The Market Cap of Envair Electrodyne Ltd is 35.6 Cr..
What is the current Stock Price of Envair Electrodyne Ltd as on 06 November 2025?
The current stock price of Envair Electrodyne Ltd as on 06 November 2025 is 76.8.
What is the High / Low of Envair Electrodyne Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Envair Electrodyne Ltd stocks is 182/68.0.
What is the Stock P/E of Envair Electrodyne Ltd?
The Stock P/E of Envair Electrodyne Ltd is .
What is the Book Value of Envair Electrodyne Ltd?
The Book Value of Envair Electrodyne Ltd is 17.8.
What is the Dividend Yield of Envair Electrodyne Ltd?
The Dividend Yield of Envair Electrodyne Ltd is 0.00 %.
What is the ROCE of Envair Electrodyne Ltd?
The ROCE of Envair Electrodyne Ltd is 2.25 %.
What is the ROE of Envair Electrodyne Ltd?
The ROE of Envair Electrodyne Ltd is 5.88 %.
What is the Face Value of Envair Electrodyne Ltd?
The Face Value of Envair Electrodyne Ltd is 10.0.